146 related articles for article (PubMed ID: 6726962)
1. The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate.
Maatman TJ; Gupta MK; Montie JE
J Urol; 1984 Jul; 132(1):58-60. PubMed ID: 6726962
[TBL] [Abstract][Full Text] [Related]
2. The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate.
Maatman TJ
J Urol; 1989 Jun; 141(6):1378-80. PubMed ID: 2470927
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer.
Mannini D; Maver P; Aiello E; Corrado G; Vecchi F; Bellanova B; Marengo M
Urol Res; 1988; 16(1):9-12. PubMed ID: 2449758
[TBL] [Abstract][Full Text] [Related]
4. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
Bruce AW; Mahan DE; Sullivan LD; Goldenberg L
J Urol; 1981 Mar; 125(3):357-60. PubMed ID: 6162968
[TBL] [Abstract][Full Text] [Related]
5. Circadian and day-to-day variation of prostatic acid phosphatase.
Nissenkorn I; Mickey DD; Miller DB; Soloway MS
J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of fluctuation of serum tumor markers in advanced cancer of prostate.
Maatman TJ
Urology; 1993 Dec; 42(6):672-6. PubMed ID: 7504849
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay versus counterimmune electrophoresis for measurement of serum prostatic acid phosphatase.
Wright GL; Schellhammer PF; Leffell MS; Sieg SM; Brassil BN
Urology; 1982 Apr; 19(4):351-5. PubMed ID: 7072025
[TBL] [Abstract][Full Text] [Related]
8. Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Ahmann FR; Schifman RB
J Urol; 1987 Mar; 137(3):431-4. PubMed ID: 2434667
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
[TBL] [Abstract][Full Text] [Related]
10. Circadian variation of different fractions of serum acid phosphatase.
Schmeller NT; Bauer HW
Prostate; 1983; 4(4):391-5. PubMed ID: 6191317
[TBL] [Abstract][Full Text] [Related]
11. Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
Fair WR; Heston WD; Kadmon D; Crane DB; Catalona WJ; Ladenson JH; McDonald JM; Noll BW; Harvey G
J Urol; 1982 Oct; 128(4):735-8. PubMed ID: 6183457
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
Vihko P; Kontturi M; Lukkarinen O; Vihko R
J Urol; 1985 Jun; 133(6):979-82. PubMed ID: 3999224
[TBL] [Abstract][Full Text] [Related]
13. Elevated prostatic acid phosphatase: a prognostic factor for stage C adenocarcinoma of the prostate.
Babaian RJ; Orlando RP
J Urol; 1986 Nov; 136(5):1035-7. PubMed ID: 3095565
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
Wadström J; Huber P; Rutishauser G
Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prostatic acid phosphatase assays.
Wise WS; Kandaswamy K
Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
[TBL] [Abstract][Full Text] [Related]
16. Comparison of countercurrent immunoelectrophoretic assay with commercial radioimmunoassay kits for measuring prostatic acid phosphatase.
Wright GL; Schellhammer PF; Brassil DN; Sieg SM; Leffell MS
Clin Chem; 1981 Oct; 27(10):1747-52. PubMed ID: 6169470
[TBL] [Abstract][Full Text] [Related]
17. Prostatic acid phosphatase: its current clinical status.
Heller JE
J Urol; 1987 Jun; 137(6):1091-103. PubMed ID: 3295298
[No Abstract] [Full Text] [Related]
18. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
[TBL] [Abstract][Full Text] [Related]
19. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
Griffiths J; Rippe DF; Panfili PR
Clin Chem; 1982 Jan; 28(1):183-6. PubMed ID: 7055908
[TBL] [Abstract][Full Text] [Related]
20. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
